stars 1 stars 2 stars 3

AmbioPharm, a global peptide CDMO, was founded in 2005 and is headquartered in North Augusta, South Carolina, USA specializing in developing highly efficient manufacturing processes for peptide-based Active Pharmaceutical Ingredients (APIs) at small to very large scales. In our manufacturing facilities in South Carolina, USA and Shanghai, China, we manufacture New Chemical Entities (NCEs) under cGMP for clients worldwide. Both facilities have been inspected multiple times by the FDA with excellent outcomes.

View Top Employees from AmbioPharm - A Global Peptide CDMO

AmbioPharm - A Global Peptide CDMO Questions

The AmbioPharm - A Global Peptide CDMO annual revenue was $36.9 million in 2024.

Tim Nieters is the CEO of AmbioPharm - A Global Peptide CDMO.

192 people are employed at AmbioPharm - A Global Peptide CDMO.

AmbioPharm - A Global Peptide CDMO is based in North Augusta, South Carolina.

The NAICS codes for AmbioPharm - A Global Peptide CDMO are [32, 3254, 32541, 325].

The SIC codes for AmbioPharm - A Global Peptide CDMO are [283, 28].

Top AmbioPharm - A Global Peptide CDMO Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users